This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Will Stronger Premiums Drive Everest Re (RE) Q3 Earnings?
by Zacks Equity Research
Everest Re Group's (RE) third-quarter results are likely to benefit from better results at both insurance and Reinsurance segments.
New Strong Sell Stocks for October 23rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Can Stronger Premiums Drive Torchmark's (TMK) Q3 Earnings?
by Zacks Equity Research
Higher premiums at Life Insurance and Health segments plus better investment results might aid Torchmark (TMK) in Q3.
Will Cat Loss Ail Cincinnati Financial's (CINF) Q3 Earnings?
by Zacks Equity Research
Improved premiums and robust investment results are likely to aid Cincinnati Financial's (CINF) results in Q3. However, catastrophe loss and rising expenses might be downsides.
Arthur J. Gallagher (AJG) Q3 Earnings: What's in Store?
by Zacks Equity Research
Stronger revenues and better-than-expected organic growth might aid Arthur J. Gallagher's (AJG) Q3. But rising expenses might be a drag.
Everest Re (RE) Q3 Earnings Preview: What to Expect
by Zacks Equity Research
Everest Re (RE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aflac (AFL) to Report Q3 Earnings: Will It Beat Estimates?
by Zacks Equity Research
Aflac (AFL) Q3 results should gain from higher revenues at both its segments, partly offset by higher expenses.
Can Unum U.S.' Strength Drive Unum Group (UNM) Q3 Earnings?
by Zacks Equity Research
Strong performance at Unum U.S. and Colonial Life, premium growth across core business lines and better investment results are likely to up Unum Group's (UNM) Q3.
Can Higher Premiums Contribute to Chubb's (CB) Q3 Earnings?
by Zacks Equity Research
Premium growth as well as better investment results are likely to drive Chubb's results (CB) in Q3. However, exposure to catastrophe loss might be a dampener.
Can Higher Premiums Drive Travelers' (TRV) Q3 Earnings?
by Zacks Equity Research
Strong growth across businesses, improved combined ratio along with higher premiums and better investment results might aid Travelers (TRV) in Q3. But cat loss exposure might be a spoilsport.
Everest Re Gains From Wide Product Portfolio, Cat Loss a Woe
by Zacks Equity Research
Everest Re (RE) continues to impress with wide product portfolio, top-line growth and robust capital position. However, exposure to cat loss remain a dampener.
Why Is Everest Re (RE) Up 1.9% Since Last Earnings Report?
by Zacks Equity Research
Everest Re (RE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Everest Re (RE) Earnings Miss Estimates in Q2, Plunge Y/Y
by Zacks Equity Research
Higher premiums as well as net investment income fuel Everest Re's (RE) revenue growth while a significant increase in expenses plays spoilsport.
Everest Re (RE) Q2 Earnings Miss Estimates
by Zacks Equity Research
Everest Re (RE) delivered earnings and revenue surprises of -2.97% and 9.03%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Insurers Reporting Earnings on Jul 30: L, RE, UNM, CNA, MCY
by Zacks Equity Research
A favorable operating environment, improving rates and lower taxes should drive the insurers' second-quarter performance.
RE vs. RNR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
RE vs. RNR: Which Stock Is the Better Value Option?
RE vs. RNR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
RE vs. RNR: Which Stock Is the Better Value Option?
Fidelity National (FNF) Q2 Earnings Top, Title Business Solid
by Zacks Equity Research
Fidelity National's (FNF) strong performance at its Title segment drives the second-quarter results.
4 Dirt-Cheap PEG Stocks Suitable for Value Investors
by Zacks Equity Research
For investors looking to escape value traps, it is vital to determine where the stock is headed in the next 12 to 24 months.
Progressive (PGR) Q2 Earnings Beat on Higher Premiums
by Zacks Equity Research
Progressive's (PGR) second quarter reflects an improved top line and the impact of lower taxes offsets increase in expenses.
Top Ranked Momentum Stocks to Buy for July 17th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th:
8 Reasons Why You Should Retain Everest Re in Your Portfolio
by Zacks Equity Research
We focus on eight factors, which make shares of Everest Re (RE) an attractive pick to yield better returns over a longer term.
5 Top-Ranked Insurance Stocks to Enhance Portfolio in 2H
by Tanuka De
We bring you five top-ranked picks from insurance industry for the second half of 2018, poised to enrich portfolio on the back of a favorable operating environment.
Progressive Rises 36% in a Year: Will the Bull Run Continue?
by Zacks Equity Research
Shares of Progressive (PGR) surge 36% in a year, backed by solid fundamentals and initiatives to ramp up growth.
RE or RNR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
RE vs. RNR: Which Stock Is the Better Value Option?